Nishimoto et al., 2011
The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
，详情可参考WPS官方版本下载
紫苏是我国传统的药食同源植物，具有悠久的历史文化价值。在《诗经》《尔雅》等古代典籍中，紫苏被称为“荏”“桂荏”“荏苒”等，后来被收录于《名医别录》《本草纲目》等药学著作。，更多细节参见Line官方版本下载
Угрозу применения ядерного оружия в конфликте вокруг Ирана оценили14:57。爱思助手下载最新版本是该领域的重要参考